TipRanks
55% OFF
PC:ELY3X

Elysium Therapeutics

1201 E Market St. Suite 604 Akron, OH 44305, UShttps://www.elysiumrx.com/Therapeutics

Elysium Therapeutics is an emerging biopharmaceutical company developing treatments to prevent and reverse overdoses caused by highly potent synthetic opioids, with a specific focus on oral fentanyl and nitazenes. The company is advancing SOOPR™, a rapid-onset, long-acting naloxone prodrug rescue therapy, and developing SMART™ and O2P™ product approaches to improve opioid safety and reduce overdose fatalities.

Leadership & Board

Current Number of Employees
4
Current LinkedIn Followers
288

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$8M
Total Funding Rounds
1
Latest Funding Amount
$8M
Latest Funding Round
Convertible Notes
Post-Money Valuation
―

Employee Trend

Elysium Therapeutics had 4 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.

4Latest Employee Count
0(0.00%)Week-Over-Week Change
01234Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Social Trend

Elysium Therapeutics had 288 followers as of October 12, 2026. The number of followers increased by 0 (0.00%) week-over-week.

288Latest Followers Count
0(0.00%)Week-Over-Week Change
0100200300400Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 28, 2026Convertible Notes$7.50M―

Similar Companies

A snapshot of private companies similar to Elysium Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis